Clinical parameters and biomarkers for anti-TNF treatment prognosis in rheumatoid arthritis patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical parameters and biomarkers for anti-TNF treatment prognosis in rheumatoid arthritis patients

Published:2014-08-02 Issue:12 Volume:33 Page:1707-1714
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Cuchacovich Miguel,Bueno Daniel,Carvajal Rodrigo,Bravo Nicolás,Aguillón Juan Carlos,Catalán Diego,Soto Lilian

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s10067-014-2756-2.pdf

Reference50 articles.

1. Bazzoni F, Beutler B (2000) The tumor necrosis factor ligand and receptor families. N Engl J Med 334:1717–1725

2. Brennan FM, Chantry D, Jackson A, Maini R, Feldmann M (1989) Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 2:244–247

3. Feldmann M, Maini SR (2008) Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics. Immunol Rev 223:7–19

4. Emery P, Breedveld FC, Hall S, Durez P, Chang DJ, Robertson D et al (2008) Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial. Lancet 372:375–382

5. Emery P, Dorner T (2011) Optimising treatment in rheumatoid arthritis: a review of potential biological markers of response. Ann Rheum Dis 70:2063–2070

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of high rheumatoid factor levels on treatment outcomes with certolizumab pegol and adalimumab in patients with rheumatoid arthritis;Rheumatology;2024-09-02

2. Rheumatoid factor titers, but not Fc fragments, may be strongly associated with drug survival of anti-TNF agents in patients with rheumatoid arthritis;Northern Clinics of Istanbul;2024

3. Novel DNA methylome biomarkers associated with adalimumab response in rheumatoid arthritis patients;Frontiers in Immunology;2023-12-22

4. Des titres élevés de facteur rhumatoïde (FR) ont-ils un impact sur la réponse aux anti-TNF ? Comparaison entre certolizumab pegol et adalimumab chez des patients atteints de PR présentant des titres élevés de FR : analyse post-hoc d’une étude de phase IV;Revue du Rhumatisme;2023-12

5. The modulatory effects of ketoconazole on cytokine changes induced by selective surgical stress in male rats;Comparative Clinical Pathology;2022-06-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3